Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00547417
What this trial is testing

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Who this might be right for
Impotence
Eli Lilly and Company 1,933
Large-scale testing (Phase 3)Study completedNCT00406640
What this trial is testing

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Who this might be right for
DepressionDepressive DisorderDepressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer 595
Testing effectiveness (Phase 2)Active Not RecruitingNCT06730750
What this trial is testing

BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 360
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Testing effectiveness (Phase 2)WithdrawnNCT01913691
What this trial is testing

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04123418
What this trial is testing

WVT078 in Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
Novartis Pharmaceuticals 56
Post-approval studies (Phase 4)Study completedNCT01706510
What this trial is testing

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

Who this might be right for
Coronary Artery Disease
Rapid City Regional Hospital, Inc 28
Testing effectiveness (Phase 2)Study completedNCT00085813
What this trial is testing

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT01197560
What this trial is testing

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene 111
Testing effectiveness (Phase 2)Study completedNCT00303524
What this trial is testing

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Who this might be right for
Breast Cancer
AstraZeneca 170
Post-approval studies (Phase 4)WithdrawnNCT03381859
What this trial is testing

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Looking for participantsNCT07704580
What this trial is testing

Phase 1b/2 Study of IV Sarilumab in Adult With RA

Who this might be right for
Rheumatoid Arthritis
Sanofi 140
Testing effectiveness (Phase 2)Looking for participantsNCT03020979
What this trial is testing

A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites

Who this might be right for
Malignant AscitesApatinib
The First Affiliated Hospital of Bengbu Medical University 120
Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50
Large-scale testing (Phase 3)Study completedNCT01650246
What this trial is testing

Open-Label Lesinurad Monotherapy Extension Study in Gout

Who this might be right for
Gout
Ardea Biosciences, Inc. 143
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Large-scale testing (Phase 3)Study completedNCT02366143
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 1,202
Early research (Phase 1)Not Yet RecruitingNCT07645235
What this trial is testing

Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women

Who this might be right for
Urinary Tract Infections
GlaxoSmithKline 8
Early research (Phase 1)UnknownNCT04678908
What this trial is testing

Injection HB0025 in Patients With Advanced Solid Tumors

Who this might be right for
Tumor, Subjects
Huabo Biopharm Co., Ltd. 154
Early research (Phase 1)Study completedNCT06693908
What this trial is testing

Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Moderate to Severe Ulcerative Colitis
Genentech, Inc. 24
Next Page